Cargando…

Drug resistance to sulphadoxine-pyrimethamine in Plasmodium falciparum malaria in Mlimba, Tanzania

BACKGROUND: Sulphadoxine-pyrimethamine (SP) has been and is currently used for treatment of uncomplicated Plasmodium falciparum malaria in many African countries. Nevertheless, the response of parasites to SP treatment has shown significant variation between individuals. METHODS: The genes for dihyd...

Descripción completa

Detalles Bibliográficos
Autores principales:	Mbugi, Erasto V, Mutayoba, Benezeth M, Malisa, Allen L, Balthazary, Sakurani T, Nyambo, Thomas B, Mshinda, Hassan
Formato:	Texto
Lenguaje:	English
Publicado:	BioMed Central 2006
Materias:	Research
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC1636063/ https://www.ncbi.nlm.nih.gov/pubmed/17076899 http://dx.doi.org/10.1186/1475-2875-5-94

Ejemplares similares

Efficacy of sulphadoxine-pyrimethamine + artesunate, sulphadoxine-pyrimethamine + amodiaquine, and sulphadoxine-pyrimethamine alone in uncomplicated falciparum malaria in Mali
por: Maiga, Hamma, et al.
Publicado: (2015)

The evolution of pyrimethamine resistant dhfr in Plasmodium falciparum of south-eastern Tanzania: comparing selection under SP alone vs SP+artesunate combination
por: Malisa, Allen L, et al.
Publicado: (2011)

Drug coverage in treatment of malaria and the consequences for resistance evolution - evidence from the use of sulphadoxine/pyrimethamine
por: Malisa, Allen L, et al.
Publicado: (2010)

Chloroquine/Sulphadoxine-Pyrimethamine for Gambian Children with Malaria: Transmission to Mosquitoes of Multidrug-Resistant Plasmodium falciparum
por: Hallett, Rachel L, et al.
Publicado: (2006)

Mapping sulphadoxine-pyrimethamine-resistant Plasmodium falciparum malaria in infected humans and in parasite populations in Africa
por: Okell, Lucy C., et al.
Publicado: (2017)

The genetic change in P. falciparum populations of rural Tanzania resulting from national policy on firstline malaria treatment and pilot Sulfadoxine/pyrimethamine and Artesunate combination
por: Malisa, Allen, et al.
Publicado: (2010)

Efficacy of Artesunate + Sulphadoxine-Pyrimethamine (AS + SP) and Amodiaquine + Sulphadoxine-Pyrimethamine (AQ + SP) for Uncomplicated falciparum Malaria in Equatorial Guinea (Central Africa)
por: Charle, Pilar, et al.
Publicado: (2009)

High Resistance of Plasmodium falciparum to Sulphadoxine/Pyrimethamine in Northern Tanzania and the Emergence of dhps Resistance Mutation at Codon 581
por: Gesase, Samwel, et al.
Publicado: (2009)

Chloroquine and sulphadoxine-pyrimethamine sensitivity of Plasmodium falciparum parasites in a Brazilian endemic area
por: Gama, Bianca Ervatti, et al.
Publicado: (2009)

High multiple mutations of Plasmodium falciparum-resistant genotypes to sulphadoxine-pyrimethamine in Lagos, Nigeria
por: Quan, Hong, et al.
Publicado: (2020)

Efficacy of sulphadoxine-pyrimethamine with or without artesunate for the treatment of uncomplicated Plasmodium falciparum malaria in southern Mozambique: a randomized controlled trial
por: Allen, Elizabeth N, et al.
Publicado: (2009)

Primaquine Clears Submicroscopic Plasmodium falciparum Gametocytes that Persist after Treatment with Sulphadoxine-Pyrimethamine and Artesunate
por: Shekalaghe, Seif, et al.
Publicado: (2007)

Genetic polymorphisms associated with sulphadoxine-pyrimethamine drug resistance among Plasmodium falciparum field isolates in malaria endemic areas of Assam
por: Sharma, J, et al.
Publicado: (2015)

Decreased availability of antimalarials in the private sector following the policy change from chloroquine to sulphadoxine-pyrimethamine in the Kilombero Valley, Tanzania
por: Hetzel, Manuel W, et al.
Publicado: (2006)

Evaluation of dihydrofolate reductase and dihydropteroate synthetase genotypes that confer resistance to sulphadoxine-pyrimethamine in Plasmodium falciparum in Haiti
por: Carter, Tamar E, et al.
Publicado: (2012)

Prevalence of the molecular marker of Plasmodium falciparum resistance to chloroquine and sulphadoxine/pyrimethamine in Benin seven years after the change of malaria treatment policy
por: Ogouyèmi-Hounto, Aurore, et al.
Publicado: (2013)

Efficacy and Tolerability of Malartin and Sulphadoxine-Pyrimethamine Combination against Uncomplicated Falciparum Malaria in Dibanda, Southwest Cameroon
por: Kimbi, Helen Kuokuo, et al.
Publicado: (2012)

Low risk of recurrence following artesunate–Sulphadoxine–pyrimethamine plus primaquine for uncomplicated Plasmodium falciparum and Plasmodium vivax infections in the Republic of the Sudan
por: Hamid, Muzamil Mahdi Abdel, et al.
Publicado: (2018)

Low prevalence of the molecular markers of Plasmodium falciparum resistance to chloroquine and sulphadoxine/pyrimethamine in asymptomatic children in Northern Benin
por: Ogouyèmi-Hounto, Aurore, et al.
Publicado: (2013)

A Study of Synergy of Combination of Eosin B with Chloroquine, Artemisinin, and Sulphadoxine-Pyrimethamine on Plasmodium falciparum In Vitro and Plasmodium berghei In Vivo
por: Sadeghi, Sedigheh, et al.
Publicado: (2020)

Media, Health Workers, and Policy Makers' Relationship and Their Impact on Antimalarial Policy Adoption: A Population Genetics Perspective
por: Malisa, Allen, et al.
Publicado: (2011)

Efficacy of sulphadoxine-pyrimethamine for intermittent preventive treatment of malaria in pregnancy, Mansa, Zambia
por: Tan, Kathrine R, et al.
Publicado: (2014)

Randomised Trial of Chloroquine/Sulphadoxine-Pyrimethamine in Gambian Children with Malaria: Impact against Multidrug-Resistant P. falciparum
por: Dunyo, Samuel, et al.
Publicado: (2006)

Effectiveness of Intermittent Preventive Treatment in Pregnancy with Sulphadoxine-Pyrimethamine against Submicroscopic falciparum Malaria in Central Region, Ghana
por: Nwaefuna, Ekene K., et al.
Publicado: (2015)

Inequities in the use of sulphadoxine-pyrimethamine for malaria prophylaxis during pregnancy in Nigeria
por: Ndu, Anne, et al.
Publicado: (2020)

Efficacy of amodiaquine, sulphadoxine-pyrimethamine and their combination for the treatment of uncomplicated Plasmodium falciparum malaria in children in Cameroon at the time of policy change to artemisinin-based combination therapy
por: Mbacham, Wilfred F, et al.
Publicado: (2010)

Molecular monitoring of Plasmodium falciparum super-resistance to sulfadoxine–pyrimethamine in Tanzania
por: Kavishe, Reginald A., et al.
Publicado: (2016)

Factors affecting uptake of optimal doses of sulphadoxine-pyrimethamine for intermittent preventive treatment of malaria in pregnancy in six districts of Tanzania
por: Exavery, Amon, et al.
Publicado: (2014)

Extended high efficacy of the combination sulphadoxine-pyrimethamine with artesunate in children with uncomplicated falciparum malaria on the Benin coast, West Africa
por: Nahum, Alain, et al.
Publicado: (2009)

Prevalence of mutations associated with antimalarial drugs in Plasmodium falciparum isolates prior to the introduction of sulphadoxine-pyrimethamine as first-line treatment in Iran
por: Zakeri, Sedigheh, et al.
Publicado: (2007)

Effectiveness of antenatal intermittent preventive treatment for malaria with sulphadoxine-pyrimethamine on peripartum outcomes
por: Godwin, Isaac Okezie, et al.
Publicado: (2022)

Molecular monitoring of Plasmodium falciparum resistance to artemisinin in Tanzania
por: Mugittu, Kefas, et al.
Publicado: (2006)

Adding artesunate to sulphadoxine-pyrimethamine greatly improves the treatment efficacy in children with uncomplicated falciparum malaria on the coast of Benin, West Africa
por: Nahum, Alain, et al.
Publicado: (2007)

Analysis of sulphadoxine/pyrimethamine resistance-conferring mutations of Plasmodium falciparum from Mozambique reveals the absence of the dihydrofolate reductase 164L mutant
por: Fernandes, Natércia, et al.
Publicado: (2007)

Temporal trends of sulphadoxine-pyrimethamine (SP) drug-resistance molecular markers in Plasmodium falciparum parasites from pregnant women in western Kenya
por: Iriemenam, Nnaemeka C, et al.
Publicado: (2012)

Therapeutic efficacy of sulphadoxine-pyrimethamine and chloroquine for the treatment of uncomplicated malaria in pregnancy in Burkina Faso
por: Coulibaly, Sheick Oumar, et al.
Publicado: (2006)

Plasmodium vivax dhfr and dhps mutations in isolates from Madagascar and therapeutic response to sulphadoxine-pyrimethamine
por: Barnadas, Céline, et al.
Publicado: (2008)

Prevalence of drug resistance associated mutations in Plasmodium vivax against sulphadoxine-pyrimethamine in southern Pakistan
por: Raza, Afsheen, et al.
Publicado: (2013)

Rapid increase of Plasmodium falciparum dhfr/dhps resistant haplotypes, after the adoption of sulphadoxine-pyrimethamine as first line treatment in 2002, in southern Mozambique
por: Enosse, Sonia, et al.
Publicado: (2008)

Selection of pfdhfr/pfdhps alleles and declining artesunate/sulphadoxine-pyrimethamine efficacy against Plasmodium falciparum eight years after deployment in eastern Sudan
por: Gadalla, Nahla B, et al.
Publicado: (2013)

Cannot write session to /tmp/vufind_sessions/sess_bhcd934pmfakp03tc9vn08hur9